Rainbow Childrens Medicare Ltd
Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology. [1] It is country’s largest pediatric hospital chain with 16 hospitals spread across 6 cities.[2]
- Market Cap ₹ 13,506 Cr.
- Current Price ₹ 1,330
- High / Low ₹ 1,710 / 1,206
- Stock P/E 53.2
- Book Value ₹ 149
- Dividend Yield 0.23 %
- ROCE 18.7 %
- ROE 17.4 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 33.7% CAGR over last 5 years
- Company's median sales growth is 25.1% of last 10 years
- Company's working capital requirements have reduced from 45.4 days to 19.4 days
Cons
- Stock is trading at 8.90 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122 | 169 | 234 | 321 | 402 | 543 | 719 | 650 | 974 | 1,174 | 1,297 | 1,516 | 1,566 | |
| 98 | 128 | 204 | 266 | 332 | 391 | 519 | 485 | 666 | 774 | 865 | 1,022 | 1,064 | |
| Operating Profit | 24 | 41 | 30 | 55 | 69 | 151 | 201 | 165 | 308 | 400 | 432 | 494 | 502 |
| OPM % | 20% | 24% | 13% | 17% | 17% | 28% | 28% | 25% | 32% | 34% | 33% | 33% | 32% |
| 3 | 10 | 16 | 11 | 10 | 8 | 10 | 10 | 19 | 31 | 37 | 51 | 56 | |
| Interest | 3 | 3 | 3 | 3 | 4 | 42 | 48 | 46 | 56 | 58 | 63 | 77 | 73 |
| Depreciation | 13 | 9 | 18 | 22 | 28 | 60 | 69 | 73 | 83 | 90 | 112 | 138 | 139 |
| Profit before tax | 11 | 38 | 24 | 41 | 47 | 58 | 93 | 56 | 187 | 282 | 295 | 330 | 345 |
| Tax % | 53% | 35% | 28% | 24% | 22% | 22% | 41% | 29% | 26% | 25% | 26% | 26% | |
| 5 | 25 | 17 | 31 | 36 | 45 | 55 | 40 | 139 | 212 | 218 | 244 | 255 | |
| EPS in Rs | 8.56 | 26.74 | 18.22 | 33.78 | 8.25 | 10.14 | 12.68 | 9.10 | 14.70 | 20.77 | 21.38 | 23.97 | 24.99 |
| Dividend Payout % | 23% | 7% | 11% | 7% | 12% | 10% | 16% | 0% | 14% | 14% | 14% | 13% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 16% |
| 3 Years: | 16% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 34% |
| 3 Years: | 20% |
| TTM: | 10% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 18% |
| 1 Year: | -16% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 20% |
| 3 Years: | 20% |
| Last Year: | 17% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 9 | 44 | 44 | 44 | 44 | 94 | 102 | 102 | 102 | 102 |
| Reserves | 144 | 166 | 275 | 308 | 307 | 317 | 350 | 391 | 498 | 958 | 1,157 | 1,367 | 1,416 |
| 24 | 22 | 24 | 26 | 24 | 476 | 501 | 529 | 592 | 570 | 765 | 764 | 816 | |
| 24 | 34 | 41 | 55 | 73 | 89 | 123 | 116 | 112 | 146 | 146 | 145 | 253 | |
| Total Liabilities | 201 | 231 | 349 | 399 | 448 | 926 | 1,019 | 1,081 | 1,296 | 1,776 | 2,170 | 2,377 | 2,587 |
| 56 | 78 | 123 | 174 | 296 | 702 | 702 | 772 | 858 | 931 | 1,253 | 1,398 | 1,650 | |
| CWIP | 4 | 35 | 31 | 7 | 12 | 23 | 43 | 29 | 6 | 23 | 20 | 28 | 53 |
| Investments | 31 | 7 | 2 | 6 | 0 | 3 | 10 | 18 | 22 | 58 | 308 | 571 | 416 |
| 109 | 111 | 194 | 212 | 140 | 199 | 265 | 262 | 409 | 764 | 590 | 380 | 468 | |
| Total Assets | 201 | 231 | 349 | 399 | 448 | 926 | 1,019 | 1,081 | 1,296 | 1,776 | 2,170 | 2,377 | 2,587 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15 | 26 | 17 | 36 | 48 | 127 | 170 | 143 | 224 | 327 | 321 | 396 | |
| -113 | -20 | -107 | -33 | -42 | -117 | -117 | -83 | -175 | -465 | -226 | -268 | |
| 98 | -7 | 93 | -1 | -7 | -9 | -52 | -61 | -44 | 143 | -102 | -118 | |
| Net Cash Flow | -0 | -1 | 3 | 1 | -2 | 2 | 2 | -1 | 4 | 5 | -7 | 10 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 10 | 11 | 10 | 16 | 14 | 24 | 22 | 25 | 15 | 18 | 20 | 19 |
| Inventory Days | 25 | 39 | 35 | 48 | 36 | 32 | 55 | 36 | 28 | 43 | 53 | 52 |
| Days Payable | 128 | 121 | 107 | 142 | 151 | 197 | 202 | 190 | 121 | 195 | 180 | 170 |
| Cash Conversion Cycle | -93 | -72 | -62 | -79 | -100 | -141 | -124 | -130 | -78 | -133 | -107 | -100 |
| Working Capital Days | -34 | -35 | -36 | -28 | -31 | -26 | -18 | -17 | -16 | 73 | 44 | 19 |
| ROCE % | 22% | 11% | 14% | 14% | 16% | 16% | 11% | 23% | 24% | 19% | 19% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 2d
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
14 Nov - Audio recording of Q2 & H1 FY26 investor/analyst conference call dated November 14, 2025 available online.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 14 Nov
-
Announcement under Regulation 30 (LODR)-Investor Presentation
13 Nov - Earnings Presentation on Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half year ended September 30, 2025.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
13 Nov - Q2 FY26: Revenue INR4,448m; PAT INR756m; CEO Abrarali Dalal from Jan 20, 2026; added 350 beds.
Annual reports
Concalls
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT REC
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022TranscriptPPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
Jun 2022Transcript PPT
Business Overview[1]
The company operates 19 hospitals and 5 clinics across 6 cities, with a total bed capacity of 1,935. It specializes in pediatric healthcare under "Rainbow Children's Hospital" and women's healthcare under "Birthright by Rainbow."